Since depletion of Brm in BRG1-deficient cancers, which are often detected in NSCLCs, has been shown to cause synthetic lethality44, CT1 might be highly effective in such SWI/SNF-dependent tumors. This evidence concerns the gene SMARCA2 and cancer.